Lantern Pharma Inc. (LTRN) Q4 2025 Earnings Call Prepared Remarks Transcript

Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid Margrave ...

Mistral AI just released a text-to-speech model it says beats ElevenLabs — and it's giving away the weights for free

Mistral AI launches Voxtral TTS, an open-weight enterprise voice model that runs on a smartphone and challenges ElevenLabs in ...

Preliminary Results for the Year Ended 31 December 2025

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company’s lead development ...

Biodexa Pharmaceuticals PLC: Preliminary Results for the Year Ended 31 December 2025

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...

Lantern Pharma outlines $15B–$20B market potential as AI-driven pipeline advances and funding needs intensify

Q4 2025. Management View. Panna Sharma, President, CEO & Director, highlighted, "2025 was a defining year for Lantern Pharma. We achi ...

What's inside a masterpiece? Laser scans and AI map paint layers molecule by molecule

Paintings are far more than dabs of oil on canvas. They are complex works of art composed of multiple layers, from primer and glues to the pigments and protective varnishes applied by the artists.
The Maravi Post

United Kingdom: Starmer must be honest about fuel shortages, inflation, the pound and gilt risks

Starmer and Reeves need to be honest about potentially imminent fuel shortages, the likelihood of UK inflation spiking again, how the pound could come under increasing pressure, and the growing risks ...